Delivery Order SPE2DR25D3201-SPE2DR26FT4MX
Award Date 12/8/25
Potential Completion Date 12/9/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,838.12 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of June 3, 2025. This non-set-aside, firm fixed price delivery order represents a competitive award to the pharmaceutical distributor for medical supply provision supporting federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,696.80 to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, a pharmaceutical product used in medical treatment. The award was made on November 12, 2025, with an ultimate completion date of November 13, 2025, under a firm fixed-price delivery order contract with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,357.44 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials. This firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. The product will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors and...
- The Defense Logistics Agency awarded a delivery order valued at $12,949.43 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials under a firm fixed-price contract. This non-set-aside award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a routine pharmaceutical procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,306.32 to AmerisourceBergen Drug Corp for the supply of Cathflo Activase 2 mg vials. This firm fixed-price delivery order was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical procurement, which falls under the...
- The Defense Logistics Agency awarded a $2,626.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award was issued on August 14, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,429.76 for Cathflo Activase 2 mg vials on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $2,737.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cathflo Activase 2 mg vials, with an ultimate completion date of November 6, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on December 2, 2025, for the supply of Cathflo Activase 2 mg vials, a thrombolytic medication used to restore patency in occluded central venous catheters. The contract is a firm fixed-price delivery order with a ceiling value of $15,761.33 and an ultimate completion date of December 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp was awarded a $3,174.48 delivery order by the Defense Logistics Agency on August 25, 2025, for the supply of Cathflo Activase 2 mg vials, with ultimate completion scheduled for August 26, 2025. This firm fixed-price contract, which was not set-aside, represents a small-value pharmaceutical procurement fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award is issued as a child delivery order under AmerisourceBergen's larger Indefinite...